How much PFAS is in Americans’ blood?

Forever chemicals found in nearly all Americans

A large study reports widespread detection of PFAS—often called “forever chemicals”—in human blood. Using more than 10,500 blood samples, researchers found PFAS in the vast majority of participants, with 98.5% testing positive for multiple PFAS and 98.8% having at least one PFAS detectable in blood.

The prevalence across such a large sample size underscores how deeply PFAS exposure has penetrated everyday life. Because PFAS are persistent chemicals used in industrial processes and products, they can remain in the environment and accumulate in human bodies over time.

The health relevance is tied to prior evidence that some PFAS are associated with serious outcomes. In this report’s framing, certain PFAS are linked to complications including:

• cancer
• infertility
• high cholesterol
• weakened immunity

That matters because the new findings strengthen the argument that PFAS exposure is not restricted to a small subset of people or a narrow exposure pathway. Instead, it appears to be a population-wide issue, which raises the urgency for both monitoring and risk reduction.

The study’s design—looking broadly across blood samples rather than only high-risk groups—also makes the results useful for public health planning. It provides a baseline for how common exposure is and can inform policies aimed at limiting PFAS in water and consumer products.

Still, the report highlights detection prevalence more than it details causal mechanisms for each health outcome. Overall, the key takeaway is the scale: PFAS presence in blood is nearly universal, and the potential long-term health implications are therefore a major concern for regulators and clinicians.